Butterfly Network, Inc.

Butterfly Network, Inc.(BFLY)の株式分析

$7.310

-0.156 (-2.14%)終値時点

Loading chart…
高値
7.550
始値
7.460
出来高加重平均価格
7.38
出来高
3.48M
時価総額
183.27M
安値
7.265
売買代金
25.64M
EV/EBITDA(TTM)
-47.75

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software.

AI分析 of Butterfly Network, Inc. (BFLY)

中立

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

バリュエーション指標

Butterfly Network, Inc.(BFLY)の現在の予想PERは0.00で、5年平均は-5.58です。

予想PER

割高
5年平均 P/E
-5.58
現在のP/E
0.00
割高
-1.74
割安
-9.43

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
-10.59
現在のEV/EBITDA
-47.75
割高
1.87
割安
-23.05

予想PSR

割高
5年平均 P/S
7.69
現在のP/S
13.20
割高
12.39
割安
2.99

Alphio AI による BFLY の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%BFLY

$4.30

シナリオ価格

基

基本

基本 · 50%BFLY

$3.65

シナリオ価格

弱

弱気

弱気 · 25%BFLY

$3.17

シナリオ価格

BFLY を保有するクジラ

F

Fosun International Holdings Ltd.

+ を保有BFLY

-4.55%

3か月リターン

H

Hood River Capital Management LLC

+ を保有BFLY

-11.98%

3か月リターン

イベントタイムライン

2026-10-13 (ET)

08:30:00

VCOM and Butterfly Network Form Long-Term Alliance

2026-10-06 (ET)

16:30:00

Bridge Neurotech and Butterfly Network Sign R&D Agreement

2026-10-05 (ET)

08:30:00

Butterfly Network Appoints Mike Noonen to Board of Directors

2026-10-01 (ET)

08:30:00

Mendaera and Butterfly Network Launch Focalist System

2026-09-22 (ET)

12:30:00

Butterfly Network Shares Rise 17.7% to $9.58

ニュース

BFLY のよくある質問 — Alphio AI が回答

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める